Wire
Sonoma Pharmaceuticals Receives FDA Approval for Microdacyn's Expanded Indications, Packaging Options
Sonoma Pharmaceuticals (SNOA) received a new approval from the US Food and Drug Administration for the Microdacyn wound irrigation solution's expanded indications and packaging options, the company said Tuesday.With the new approval, Microdacyn can now be used for cleansing, irrigating, moistening, debridement and removal of foreign material under a healthcare professional's supervision, and for the management of minor skin abrasions, lacerations and irritations, Sonoma said.The approval also covers packaging configurations of varying sizes and bottles, the company added.Price: $1.22, Change: $-0.01, Percent Change: -0.81%
$SNOA
